Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avicanna Inc (AVCN.TO)

Avicanna Inc (AVCN.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 38,262
  • Shares Outstanding, K 26,317
  • Annual Sales, $ 168 K
  • Annual Income, $ -21,072 K
  • 60-Month Beta N/A
  • Price/Sales 82.99
  • Price/Cash Flow N/A
  • Price/Book 1.72

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.38 +5.07%
on 07/15/20
1.60 -9.37%
on 07/20/20
-0.05 (-3.33%)
since 07/10/20
3-Month
1.30 +11.54%
on 06/15/20
1.95 -25.64%
on 05/19/20
-0.50 (-25.64%)
since 05/08/20
52-Week
0.66 +119.70%
on 03/12/20
4.90 -70.41%
on 08/20/19
-3.50 (-70.71%)
since 08/09/19

Most Recent Stories

More News
Avicanna and Red White & Bloom Enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States

The partnership allows for both companies to stake a claim in the expanding $532 billion   beauty  industry with the most advanced and only clinically backed CBD skin care line

AVCNF : 1.0700 (+1.90%)
AVCN.TO : 1.45 (+1.40%)
Avicanna and Red White & Bloom Enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States

The partnership allows for both companies to stake a claim in the expanding $532 billion beauty industry with the most advanced and only clinically backed CBD skin care line

AVCN.TO : 1.45 (+1.40%)
AVCNF : 1.0700 (+1.90%)
RWB.CN : 0.960 (-2.04%)
RWBYF : 0.7298 (-0.03%)
Avicanna Inc. to Host Second Quarter 2020 Investor Conference Call

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/...

AVCN.TO : 1.45 (+1.40%)
AVCNF : 1.0700 (+1.90%)
Avicanna announces the award of two Canadian government NSERC grants: 1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph

In addition to a recent MITACS award, Dr. Christine Allen, a Professor at the University of Toronto, was awarded an NSERC Alliance grant for development of cannabinoid-based pharmaceutical formulations...

AVCN.TO : 1.45 (+1.40%)
AVCNF : 1.0700 (+1.90%)
Avicanna Announces Participation in a Medical Cannabis Real-World Evidence (MC-RWE) Research Study Led by the University Health Network in Partnership with Medical Cannabis by Shoppers(TM) using its Rho Phyto(TM) Advanced Medical Cannabis Formulary of Products

The Rho Phyto portfolio contains a full formulary of products including oil drops, sublingual sprays, capsules, and topicals that have controlled dosing, enhanced absorption and stability studies supported...

AVCN.TO : 1.45 (+1.40%)
AVCNF : 1.0700 (+1.90%)
Avicanna Announces Co-development of a Cannabinoid-based Formulation for Treatment of COVID-19 related Lung Inflammation with Support from the Mitacs Accelerate Program

Avicanna further expands its existing research collaboration with Dr. Christine Allen's Research Group at the University of Toronto to include the development of a cannabinoid-based pharmaceutical for...

AVCN.TO : 1.45 (+1.40%)
AVCNF : 1.0700 (+1.90%)
Avicanna to Host Virtual Symposium Titled "Medical Cannabis 2.0" on July 21st, 2020 in Partnership with Medical Cannabis By Shoppers(TM) in Anticipation of the Launch of its Rho Phyto(TM) Product Line

- - -The symposium will present the evolution of medical cannabis including the Avicanna-led advancements in R&D for novel cannabinoid delivery forms and formulations in addition to enhanced access for...

AVCN.TO : 1.45 (+1.40%)
AVCNF : 1.0700 (+1.90%)
Avicanna Completes First Ever Export of Feminized Hemp Seeds For Cultivation Use to the United States and Closes the Initial Sale

Seven million CBG dominant feminized seeds have been successfully exported to the US from Colombia and an additional seventy-five million seeds remain in inventory for sale to international markets.

AVCN.TO : 1.45 (+1.40%)
AVCNF : 1.0700 (+1.90%)
Avicanna Successfully Registers the First Group of its Pura Earth(TM) CBD-Based Derma-Cosmetic Product Line in the European Union in Preparation for its Commercialization

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/...

AVCN.TO : 1.45 (+1.40%)
AVCNF : 1.0700 (+1.90%)
Avicanna Reports First Quarter 2020 Financial Results and Provides Corporate Update

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/...

AVCN.TO : 1.45 (+1.40%)
AVCNF : 1.0700 (+1.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 1.50
1st Resistance Point 1.47
Last Price 1.45
1st Support Level 1.41
2nd Support Level 1.38

See More

52-Week High 4.90
Fibonacci 61.8% 3.28
Fibonacci 50% 2.78
Fibonacci 38.2% 2.28
Last Price 1.45
52-Week Low 0.66

See More

Business Summary

Avicanna Inc is a Canada based company engaged in the medical cannabis industry. It is focused on the cultivation of non-psychoactive cannabis plants to produce Cannabidiol Extracts. The company sells its products through Pura Elements and Pura Earth brand names.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar